Zobrazeno 1 - 10
of 22
pro vyhledávání: '"John P. Kowalski"'
Autor:
Katherine A. Sitko, Lai Hong Wong, Allan E. Rettie, Gabriel Boyle, Clara J. Amorosi, John P. Kowalski, Melissa A Chiasson, Douglas M. Fowler, Maitreya J. Dunham, Matthew G. McDonald
Publikováno v:
Am J Hum Genet
CYP2C9 encodes a cytochrome P450 enzyme responsible for metabolizing up to 15% of small molecule drugs, and CYP2C9 variants can alter the safety and efficacy of these therapeutics. In particular, the anti-coagulant warfarin is prescribed to over 15 m
Autor:
Guillermo S Romano Ibarra, Biswajit Paul, Blythe D Sather, Patrick M Younan, Karen Sommer, John P Kowalski, Malika Hale, Barry Stoddard, Jordan Jarjour, Alexander Astrakhan, Hans-Peter Kiem, David J Rawlings
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016)
A naturally occurring 32-base pair deletion of the HIV-1 co-receptor CCR5 has demonstrated protection against HIV infection of human CD4+ T cells. Recent genetic engineering approaches using engineered nucleases to disrupt the gene and mimic this mut
Externí odkaz:
https://doaj.org/article/9a753dd3c9794ca9b239d6c43c9c7b98
Autor:
Michele Scian, Dale Whittington, Matthew G. McDonald, Constanze Wiek, Miklos Guttman, Allan E. Rettie, John P. Kowalski, Marco Girhard, Helmut Hanenberg
Publikováno v:
Chemical Research in Toxicology. 32:2488-2498
Cytochrome P450 4B1 (CYP4B1) has been explored as a candidate enzyme in suicide gene systems for its ability to bioactivate the natural product 4-ipomeanol (IPO) to a reactive species that causes cytotoxicity. However, metabolic limitations of IPO ne
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 51(8)
8-[(1H-1,2,3-benzotriazol-1-yl)amino]octanoic acid (8-BOA) was recently identified as a selective and potent mechanism-based inactivator (MBI) of breast cancer-associated CYP4Z1 and exhibited favourable inhibitory activity
8‐[(1H‐1,2,3‐benzotriazol‐1‐yl)amino]octanoic acid (8-BOA) was recently identified as a selective and potent mechanism-based inactivator (MBI) of breast cancer-associated CYP4Z1 and exhibited favourable inhibitory activity in vitro, thus me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01b53bcc8bf55a84f9624d1c38c8807f
Autor:
Catherine K. Yeung, John P. Kowalski, Allan E. Rettie, Matthew G. McDonald, Kenneth E. Thummel, Constanze Wiek, Lindsay M. Henderson, Helmut Hanenberg, Amanda L. Johnson, Sutapa Ray
Publikováno v:
J Pharmacol Exp Ther
CYP2C9 is a major form of human liver cytochrome P450 that is responsible for the oxidative metabolism of several widely used low-therapeutic index drugs, including (S)-warfarin and phenytoin. In a cohort of Alaska Native people, ultrarare or novel C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f47b4bcc698d24abb68096d10735750b
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85088177937
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85088177937
Autor:
Allan E. Rettie, Constanze Wiek, John P. Kowalski, Helmut Hanenberg, Robert D. Pelletier, Matthew G. McDonald
Mammary-tissue-restricted cytochrome P450 4Z1 (CYP4Z1) has garnered interest for its potential role in breast cancer progression. CYP4Z1-dependent metabolism of arachidonic acid preferentially generates 14,15-epoxyeicosatrienoic acid (14,15-EET), a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::270dcc3cbf99d1f1ecfd98c061ed0fa2
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85084692722
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85084692722
Autor:
Katherine A. Sitko, Allan E. Rettie, Maitreya J. Dunham, Rheem A. Totah, Byron Gallis, Abhinav Nath, John P. Kowalski, Lorela Paco, Sutapa Ray, Matthew G. McDonald, Douglas M. Fowler, Clara J. Amorosi
Publikováno v:
Drug Metabolism and Disposition. 45:1364-1371
CYP4Z1 is an "orphan" cytochrome P450 (P450) enzyme that has provoked interest because of its hypothesized role in breast cancer through formation of the signaling molecule 20-hydroxyeicosatetraenoic acid (20-HETE). We expressed human CYP4Z1 in Sacch
Publikováno v:
Drug Metabolism and Pharmacokinetics. 35:S27-S28
Autor:
Allan E. Rettie, Constanze Wiek, Marco Girhard, Michael C. Hutter, John P. Kowalski, Florian A. Thesseling
Publikováno v:
Arch Biochem Biophys
CYP4B1 is an enigmatic mammalian cytochrome P450 monooxygenase acting at the interface between xenobiotic and endobiotic metabolism. A prominent CYP4B1 substrate is the furan pro-toxin 4-ipomeanol (IPO). Our recent investigation on metabolism of IPO